Group One Trading’s Acurx Pharmaceuticals ACXP Stock Holding History

Group One Trading’s Portfolio ACXP Stock Details ACXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-75	Closed	-$766	–	8306
2025 Q2	$766	Sell	75 -555	-88%	-$4.47K	﹤0.01%	7606
2025 Q1	$4.91K	Buy	630 +95	+18%	+$1.28K	﹤0.01%	6654
2024 Q4	$8.71K	Buy	+535	New	+$16.1K	﹤0.01%	6168
2024 Q3	–	Sell	-1,005	Closed	-$45.2K	–	6556
2024 Q2	$45.2K	Sell	1,005 -520	-34%	-$22.9K	﹤0.01%	4591
2024 Q1	$74.7K	Sell	1,525 -1,350	-47%	-$87.7K	﹤0.01%	4395
2023 Q4	$220K	Buy	+2,875	New	+$217K	﹤0.01%	3789

Other funds holding ACXP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PFS

Prospect Financial Services Melville, New York $197M AUM 24.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Group One Trading's ACXP Position: Q2 2026 in Review

Group One Trading reduced its Acurx Pharmaceuticals (ACXP) stake by 61% in Q2 2026, selling an estimated $312 and leaving 95 shares worth $147. The position accounts for ﹤0.01% of the portfolio, ranked #7387.

Group One Trading first reported a position in ACXP in Q3 2023 and has held it in 11 quarters since. The position peaked at $33K in Q1 2024. 19 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.

Group One Trading held 95 shares of Acurx Pharmaceuticals worth $147 as of Q2 2026.
Group One Trading sold 150 Acurx Pharmaceuticals shares in Q2 2026, an estimated $312.
Acurx Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7387 holding.
Group One Trading first reported a position in Acurx Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
Group One Trading's Acurx Pharmaceuticals position peaked at $33K in Q1 2024.
19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.